Ausdal Financial Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$296K Sell
4,298
-1,132
-21% -$78.1K 0.02% 560
2025
Q1
$368K Buy
+5,430
New +$368K 0.03% 455
2024
Q2
Sell
-4,866
Closed -$388K 504
2024
Q1
$388K Buy
4,866
+15
+0.3% +$1.2K 0.05% 319
2023
Q4
$383K Buy
4,851
+749
+18% +$59.1K 0.05% 301
2023
Q3
$286K Buy
4,102
+41
+1% +$2.86K 0.04% 347
2023
Q2
$281K Buy
4,061
+68
+2% +$4.7K 0.04% 338
2023
Q1
$297K Sell
3,993
-269
-6% -$20K 0.04% 351
2022
Q4
$397K Sell
4,262
-253
-6% -$23.6K 0.06% 277
2022
Q3
$431K Buy
4,515
+94
+2% +$8.97K 0.07% 267
2022
Q2
$410K Sell
4,421
-2,674
-38% -$248K 0.06% 288
2022
Q1
$718K Buy
7,095
+425
+6% +$43K 0.1% 217
2021
Q4
$688K Sell
6,670
-53
-0.8% -$5.47K 0.09% 226
2021
Q3
$571K Sell
6,723
-58
-0.9% -$4.93K 0.08% 251
2021
Q2
$566K Sell
6,781
-299
-4% -$25K 0.09% 240
2021
Q1
$533K Buy
7,080
+880
+14% +$66.2K 0.09% 237
2020
Q4
$423K Buy
6,200
+143
+2% +$9.76K 0.08% 252
2020
Q3
$354K Sell
6,057
-3,225
-35% -$188K 0.09% 229
2020
Q2
$603K Sell
9,282
-55
-0.6% -$3.57K 0.2% 125
2020
Q1
$582K Buy
9,337
+1,134
+14% +$70.7K 0.21% 121
2019
Q4
$579K Buy
8,203
+3,637
+80% +$257K 0.17% 152
2019
Q3
$288K Buy
4,566
+134
+3% +$8.45K 0.1% 234
2019
Q2
$251K Buy
4,432
+86
+2% +$4.87K 0.1% 241
2019
Q1
$234K Buy
4,346
+76
+2% +$4.09K 0.1% 230
2018
Q4
$280K Sell
4,270
-213
-5% -$14K 0.14% 181
2018
Q3
$353K Sell
4,483
-189
-4% -$14.9K 0.1% 247
2018
Q2
$301K Sell
4,672
-28
-0.6% -$1.8K 0.09% 275
2018
Q1
$292K Buy
4,700
+293
+7% +$18.2K 0.1% 253
2017
Q4
$320K Buy
4,407
+823
+23% +$59.8K 0.11% 237
2017
Q3
$291K Sell
3,584
-102
-3% -$8.28K 0.12% 231
2017
Q2
$297K Buy
3,686
+39
+1% +$3.14K 0.13% 216
2017
Q1
$286K Buy
3,647
+456
+14% +$35.8K 0.13% 202
2016
Q4
$252K Buy
3,191
+229
+8% +$18.1K 0.12% 199
2016
Q3
$264K Buy
2,962
+7
+0.2% +$624 0.13% 186
2016
Q2
$283K Buy
+2,955
New +$283K 0.15% 172
2016
Q1
Sell
-2,195
Closed -$215K 366
2015
Q4
$215K Buy
+2,195
New +$215K 0.11% 197